Works about RITONAVIR

Results: 1087

Patient Experiences With Nirmatrelvir/Ritonavir for COVID-19 in a Collaborative Care Model: A Cross-Sectional Study on Self-Management, Information, and Medication Impact.

Published in:

Journal of Patient Experience, 2025, p. 1, doi. 10.1177/23743735251342126

By:

Santos, Beatriz;
Rousseau, Maeva;
Gauthier, Ralitza;
Calmy, Alexandra;
Schneider, Marie P.

Publication type:

Article

Potential consequences of ineffective COVID‐19 antiviral management.

Published in:

Academic Emergency Medicine, 2024, v. 31, n. 9, p. 947, doi. 10.1111/acem.14940

By:

Ko, Humphrey H. T.

Publication type:

Article

Paxlovid for nonhospitalized patients with COVID‐19.

Published in:

Academic Emergency Medicine, 2024, v. 31, n. 6, p. 621, doi. 10.1111/acem.14896

By:

Johari, Fatima;
Verma, Rajesh

Publication type:

Article

Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis.

Published in:

Indian Journal of Pharmacology, 2020, v. 52, n. 4, p. 313, doi. 10.4103/ijp.IJP_627_20

By:

Bhattacharyya, Anusuya;
Kumar, Subodh;
Sarma, Phulen;
Kaur, Hardeep;
Prajapat, Manisha;
Shekhar, Nishant;
Bansal, Seema;
Avti, Pramod;
Hazarika, Mythili;
Sharma, Saurabh;
Mahendru, Dhruv;
Prakash, Ajay;
Medhi, Bikash

Publication type:

Article

Nirmatrelvir/Ritonavir Regimen for Mild/Moderately Severe COVID-19: A Rapid Review With Meta-Analysis and Trial Sequential Analysis.

Published in:

Annals of Family Medicine, 2024, v. 22, n. 4, p. 336, doi. 10.1370/afm.3120

By:

Okoli, George N.;
Askin, Nicole;
Rabbani, Rasheda

Publication type:

Article

Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy.

Published in:

2016

By:

Ragazini, Conrado S.;
Bahamondes, Maria Valeria;
Prandini, Tatiana R. Rocha;
Brito, Milena Bastos;
Amaral, Eliana;
Bahamondes, Luis;
Duarte, Geraldo;
Quintana, Silvana Maria;
Ferriani, Rui Alberto;
Vieira, Carolina Sales

Publication type:

journal article

Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.

Published in:

Heart & Vessels, 2021, v. 36, n. 1, p. 115, doi. 10.1007/s00380-020-01671-4

By:

Moschini, Luigi;
Loffi, Marco;
Regazzoni, Valentina;
Di Tano, Giuseppe;
Gherbesi, Elisa;
Danzi, Gian Battista

Publication type:

Article

Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat.

Published in:

Journal of Pharmacy & Pharmacology, 2017, v. 69, n. 12, p. 1786, doi. 10.1111/jphp.12820

By:

Hossain, Md Amin;
Tran, Timothy;
Chen, Tianmeng;
Mikus, Gerd;
Greenblatt, David J.

Publication type:

Article

Encapsulation of ritonavir in solid lipid nanoparticles: in-vitro anti- HIV-1 activity using lentiviral particles.

Published in:

Journal of Pharmacy & Pharmacology, 2017, v. 69, n. 8, p. 1002, doi. 10.1111/jphp.12737

By:

Javan, Farzaneh;
Vatanara, Alireza;
Azadmanesh, Kayhan;
Nabi‐Meibodi, Mohsen;
shakouri, Mehdi

Publication type:

Article

Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir.

Published in:

Journal of Pharmacy & Pharmacology, 2016, v. 68, n. 5, p. 678, doi. 10.1111/jphp.12478

By:

Miller, Dave A.;
Keen, Justin M.;
Brough, Chris;
Ellenberger, Daniel J.;
Cisneros, Marshall;
Williams, Robert O.;
McGinity, James W.

Publication type:

Article

Adverse Drug Reactions during COVID-19 Treatment: A Comprehensive Analysis Focused on Hospitalized Patients, with the Use of a Survey in Cuba in 2020.

Published in:

Advances in Pharmacological & Pharmaceutical Sciences, 2023, p. 1, doi. 10.1155/2023/1995642

By:

Gil-del-Valle, Lizette;
Gravier-Hernández, Rosario;
Baldoquin-Rodríguez, Waldemar;
Sierra-Vázquez, Beatriz;
Perez-Díaz, Ana Beatriz;
Sariol-Resik, Pablo;
Prieto-Dominguez, Tatiana;
Delgado-Guerra, Mario Manuel;
Sánchez- Márquez, Joniel Arnoldo;
López-Fernández, Olga Elena;
Fonseca-Betancourt, Faustina;
Valdés-Lanza, Liana;
Orraca-Castillo, Odalys;
Van Ostade, Xaveer;
Vanden Berghe, Wim;
Vanlerberghe, Veerle;
Guzmán-Tirado, M. Guadalupe

Publication type:

Article

Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro.

Published in:

Eye (0950-222X), 2014, v. 28, n. 1, p. 93, doi. 10.1038/eye.2013.240

By:

Vadlapatla, R K;
Vadlapudi, A D;
Pal, D;
Mukherji, M;
Mitra, A K

Publication type:

Article

Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review.

Published in:

Therapeutic Advances in Vaccines & Immunotherapy, 2022, v. 10, p. 1, doi. 10.1177/25151355221097559

By:

Sanyaolu, Adekunle;
Okorie, Chuku;
Marinkovic, Aleksandra;
Prakash, Stephanie;
Williams, Martina;
Haider, Nafees;
Mangat, Jasmine;
Hosein, Zaheeda;
Balendra, Vyshnavy;
Abbasi, Abu Fahad;
Desai, Priyank;
Jain, Isha;
Utulor, Stephen;
Abioye, Amos

Publication type:

Article

The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19 treatment.

Published in:

Turkish Journal of Medical Sciences, 2021, v. 51, n. 4, p. 1624, doi. 10.3906/sag-2012-189

By:

ÇINARKA, Halit;
GÜNLÜOĞLU, Gülşah;
ÇÖRTÜK, Mustafa;
YURT, Sibel;
KIYIK, Murat;
KOŞAR, Filiz;
TANRIVERDİ, Elif;
ARSLAN, Melih Akay;
BAYDİLİ, Kürşad Nuri;
KOÇ, Aysu Sinem;
ALTIN, Sedat;
ÇETİNKAYA, Erdoğan

Publication type:

Article

Antiviral treatment of COVID-19.

Published in:

Turkish Journal of Medical Sciences, 2020, v. 50, n. SI, p. 611, doi. 10.3906/sag-2004-145

By:

ŞİMŞEK YAVUZ, Serap;
ÜNAL, Serhat

Publication type:

Article

Development and Validation of a New RP-HPLC Method for the Simultaneous Estimation of Nirmatrelvir, Ritonavir and Molnupiravir in Formulated Nanosponges, Plasma Samples and its Pharmacokinetic Study.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2024, v. 58, n. 4, p. 1299, doi. 10.5530/ijper.58.4.142

By:

Veerareddy, Vyshali;
Gandla, Kumaraswamy

Publication type:

Article

Stability Indicating RP-UPLC Method for Impurity Profiling of Darunavir and Ritonavir in Fixed Dose Drug Combination Product.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2024, v. 58, p. S558, doi. 10.5530/ijper.58.2s.58

By:

Buch, Munish;
Vaghani, Hasit

Publication type:

Article

Enhanced Solubility and Dissolution of Drug-drug Cocrystals of Lopinavir-Ritonavir.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2023, v. 57, p. s292, doi. 10.5530/ijper.57.2s.33

By:

Chaudhari, Khushbu R.;
Savjani, Jignasa K.;
Savjani, Ketan T.;
Dahiya, Sandeep;
Bhangale, Jitendra O.

Publication type:

Article

Development and Validation of RP-HPLC Method for Quantification of Total, Free and Entrapped Ritonavir in Lipid Nanocarriers and Drug content of Film Coated Fixed Dose Formulation.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2022, v. 56, p. S547, doi. 10.5530/ijper.56.3s.164

By:

Jitta, Srinivas Reddy;
Bhaskaran, Navya Ajitkumar;
Kumar, Lalit;
Shirodkar, Rupesh K.

Publication type:

Article

Insights on SARS-CoV-2: Emerging Outbreaks of Viral Infections and the Need for Heightening the Antiviral Research.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2020, v. 54, p. 390, doi. 10.5530/ijper.54.3s.137

By:

Peraman, Ramalingam;
Pemmadi, Raghuveer Varma;
Peraman, Muthukumaran;
Sure, Sathish Kumar

Publication type:

Article

Is Covid-19 Sibling of SARS AND MERS? A Review on: Novel Covid-19.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2020, v. 54, n. 3, p. 491, doi. 10.5530/ijper.54.3.97

By:

Devi, Savita;
Singh, Kamaldeep

Publication type:

Article

Design and Development of Darunavir Loaded Self Micro Emulsifying Drug Delivery System using Extreme Vertices Mixture Design in a Quality by Design Framework.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2020, v. 54, n. 2, p. 337, doi. 10.5530/ijper.54.2.39

By:

Reddy, Kavitha Arenur Narayana;
Kunchithapatham, Janakiraman;
Dang, Raman;
Ramnarayanan, Chandramouli

Publication type:

Article

Comparative Single Dose Pharmacokinetics and Bioavailability Studies of Saquinavir, Ritonavir and their Optimized Cyclodextrin Complexes after Oral Administration into Rats using LC-MS/MS.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2018, v. 52, n. 4, p. 587, doi. 10.5530/ijper.52.4.68

By:

Sogai, Bharani S.;
Narayansetty, Vikram B.;
Kolapalli, Ramana Murthy V.

Publication type:

Article

THERAPEUTIC STRATEGIES AND USE OF LOPINAVIR/RITONAVIR IN PATIENTS WITH HIGHLY RESISTANT HUMAN IMMUNODEFICIENCY VIRUS.

Published in:

Farmacia, 2024, v. 72, n. 3, p. 588, doi. 10.31925/farmacia.2024.3.13

By:

ZHONG CHEN;
TONG WANG;
CAIHONG WU;
KEJI DENG;
MIN WANG;
HUI QI;
NING WANG;
YING LI;
YONG DENG;
GUIYING CAO;
SHENGMING LIU

Publication type:

Article

Novel 1,3-Indanedione-Thiazole Hybrids as Small-Molecule SARS-COV-2 Main Protease Inhibitors With Potential anti-Coronaviral Activity.

Published in:

Polycyclic Aromatic Compounds, 2024, v. 44, n. 10, p. 6941, doi. 10.1080/10406638.2024.2318442

By:

Farghaly, Thoraya A.;
Masaret, Ghada S.;
Abdulwahab, Hanan Gaber

Publication type:

Article

Investigating Graph Invariants for Predicting Properties of Chemical Structures of Antiviral Drugs.

Published in:

Polycyclic Aromatic Compounds, 2024, v. 44, n. 10, p. 6696, doi. 10.1080/10406638.2023.2283625

By:

Samiei, Zahra;
Movahedi, Fateme

Publication type:

Article

QSPR Analysis of Some Drug Candidates Investigated for COVID-19 via New Topological Coindices.

Published in:

Polycyclic Aromatic Compounds, 2024, v. 44, n. 2, p. 1291, doi. 10.1080/10406638.2023.2191974

By:

Öztürk Sözen, Esra;
Eryaşar, Elif

Publication type:

Article

QSPR Modeling of Status-Based Topological Indices with COVID-19 Drugs.

Published in:

Polycyclic Aromatic Compounds, 2023, v. 43, n. 8, p. 6868, doi. 10.1080/10406638.2022.2127803

By:

Nagarajan, Sethumadhavan;
Priyadharsini, Gunasekaran;
Pattabiraman, Kannan

Publication type:

Article

Temperature-Based Topological Indices and QSPR Analysis of COVID-19 Drugs.

Published in:

Polycyclic Aromatic Compounds, 2023, v. 43, n. 5, p. 4148, doi. 10.1080/10406638.2022.2086271

By:

Kansal, Neha;
Garg, Pravin;
Singh, Omendra

Publication type:

Article

On Topological Descriptors and Curvilinear Regression Analysis of Antiviral Drugs Used in COVID-19 Treatment.

Published in:

Polycyclic Aromatic Compounds, 2022, v. 42, n. 10, p. 6932, doi. 10.1080/10406638.2021.1993941

By:

Ravi, Vignesh;
Siddiqui, Muhammad Kamran;
Chidambaram, Natarajan;
Desikan, Kalyani

Publication type:

Article

Quantitative Structure Analysis of Some Molecules in Drugs Used in the Treatment of COVID-19 with Topological Indices.

Published in:

Polycyclic Aromatic Compounds, 2022, v. 42, n. 8, p. 5249, doi. 10.1080/10406638.2021.1934045

By:

Havare, Özge Çolakoğlu

Publication type:

Article

Lifestyle and adherence to antiretrovirals in people with HIV in the COVID-19 pandemic.

Published in:

Revista Brasileira de Enfermagem, 2022, v. 75, p. 1, doi. 10.1590/0034-7167-2021-0644

By:

Holanda da Cunha, Gilmara;
Correia Lima, Maria Amanda;
Rodrigues Siqueira, Larissa;
Soares Monteiro Fontenele, Marina;
Lima Ramalho, Ane Kelly;
de Almeida, Paulo César

Publication type:

Article

Effectiveness and Safety of Simnotrelvir/Ritonavir and Nirmatrelvir/Ritonavir in the Treatment of Moderate to Severe COVID‐19.

Published in:

Immunity, Inflammation & Disease, 2025, v. 13, n. 4, p. 1, doi. 10.1002/iid3.70174

By:

Chen, Xin;
Lin, Xiao‐Qing;
Cheng, Fang;
Zheng, Shi‐Lin;
Zhang, Qiang;
Wu, Te;
Jiang, Xian‐Gao;
Shi, Ji‐Chan

Publication type:

Article

The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11.

Published in:

Immunity, Inflammation & Disease, 2021, v. 9, n. 3, p. 667, doi. 10.1002/iid3.415

By:

Feng, Wenli;
Yang, Jing;
Ma, Yan;
Xi, Zhiqin;
Zhao, Xiaoqin;
Zhao, Xiaoxia;
Zhao, Min

Publication type:

Article

Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre.

Published in:

Global Cardiology Science & Practice, 2021, v. 2021, n. 2, p. 1, doi. 10.21542/gcsp.2021.11

By:

Istampoulouoglou, Ioanna;
Zimmermanns, Barbara;
Grandinetti, Tanja;
Marzolini, Catia;
Harings-Kaim, Annette;
Koechlin-Lemke, Sarah;
Scholz, Irene;
Bassetti, Stefano;
Leuppi-Taegtmeyer, Anne B.

Publication type:

Article

Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-53862-y

By:

Chen, Mei-Ping;
Jiang, Di-Xuan;
Rang, Jia-Xi;
Zhuo, Hai-Bo;
Zhou, Zhi-Guo

Publication type:

Article

Nirmatrelvir/ritonavir and risk of long COVID symptoms: a retrospective cohort study.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46912-4

By:

Congdon, Seth;
Narrowe, Zev;
Yone, Nang;
Gunn, Jacob;
Deng, Yuting;
Nori, Priya;
Cowman, Kelsie;
Islam, Marjan;
Rikin, Sharon;
Starrels, Joanna

Publication type:

Article

Case report: Paralytic ileus resulted from nirmatrelvir/ritonavir-tacrolimus drug-drug interaction in a systemic lupus erythematosus patient with COVID-19.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1389187

By:

Wei Zhang;
Xingguo Zhang;
Jinming Han;
Wen Zhang;
Jiarui Xu;
Xin Zhang;
Hongjun Bian;
Chong Meng;
Deya Shang;
Yi Zhou;
Dawei Wang;
Baobao Feng

Publication type:

Article

Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal.

Published in:

Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1285078

By:

Yu Xiong;
Xiaoxing Wang;
Shu Li;
Qian Zhang;
Lijuan Guo;
Wenhui Chen;
Zhixia Zhao;
Lihong Liu

Publication type:

Article

Torsade de pointes associated with long-term antiretroviral drugs in a patient with HIV: a case report.

Published in:

2023

By:

Xuechun Mu;
Yujiao Duan;
Qiuhua Xu;
Sa Wang;
Guiju Gao;
Ning Han;
Hongxin Zhao

Publication type:

Case Study

Head-to-head comparison of azvudine and nirmatrelvir/ ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity score matching.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1274294

By:

An-Hua Wei;
Lu Zeng;
Lu Wang;
Lin Gui;
Wen-Ting Zhang;
Xue-Peng Gong;
Juan Li;
Dong Liu

Publication type:

Article

Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1210579

By:

Smith, Dallas J.;
Huichang Bi;
Hamman, Josias;
Xiaochao Ma;
Mitchell, Constance;
Nyirenda, Kumbukani;
Monera-Penduka, Tsitsi;
Oketch-Rabah, Hellen;
Paine, Mary F.;
Pettit, Syril;
Pheiffer, Wihan;
Van Breemen, Richard B.;
Embry, Michelle

Publication type:

Article

A retrospective analysis of factors associated with the length of hospital stay in COVID-19 patients treated with Nirmatrelvir/Ritonavir.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1146938

By:

Jiantao Zheng;
Wencong Hong;
Chanjuan Zhou;
Donghuang Hong;
Hong Yan;
Yanghui Shen

Publication type:

Article

Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1161897

By:

Jiayue Lu;
Hong Cai;
Yujun Hao;
Zhang Lin;
Shang Liu;
Yaping Zhan;
Li Ding;
Meilan Huang;
Zhenyuan Li;
Lan Xu;
Xiujuan Yan;
Li Yang;
He Zhang;
Wei Zhang;
Li Zhao;
Junli Zhao;
Ting Wang;
Leyi Gu

Publication type:

Article

Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1111329

By:

Mohammed, Mona A.

Publication type:

Article

Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review.

Published in:

Psychopharmacology, 2021, v. 238, n. 2, p. 329, doi. 10.1007/s00213-020-05716-4

By:

Plasencia-García, Beatriz Oda;
Rodríguez-Menéndez, Gonzalo;
Rico-Rangel, María Isabel;
Rubio-García, Ana;
Torelló-Iserte, Jaime;
Crespo-Facorro, Benedicto

Publication type:

Article

Advancements in oral therapeutic drugs for treating SARS-CoV-2 infections: A comprehensive review.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1082, doi. 10.5246/jcps.2024.11.078

By:

Li Wang;
Meng Rui;
Jun Peng;
Yun Ling

Publication type:

Article

Synthesis, characterization and catalytic assessment of novel hierarchical zeolite Hβ for the synthesis of biologically active amido alkyl naphthols.

Published in:

Research on Chemical Intermediates, 2025, v. 51, n. 3, p. 1187, doi. 10.1007/s11164-024-05484-2

By:

Mansuri, Bilal;
Lodhi, Aayushi;
Parmar, Hemant;
Dalai, Ajay;
Maheria, Kalpana

Publication type:

Article

An improved and robust scale-up process aided with identification and control of critical process impurities in darunavir ethanolate.

Published in:

Research on Chemical Intermediates, 2020, v. 46, n. 1, p. 267, doi. 10.1007/s11164-019-03948-4

By:

Girigani, Sathyanarayana;
Singh, Harnam;
Kola, Sankar Rao;
Dayanand Yelmeli, Vijayalaxmi;
Regula, Venu Gopal;
Shah, Sakshi;
Jain, Neelu;
Kumar, Pramod

Publication type:

Article

Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43706-0

By:

Wong, Carlos K. H.;
Lau, Jonathan J.;
Au, Ivan C. H.;
Lau, Kristy T. K.;
Hung, Ivan F. N.;
Peiris, Malik;
Leung, Gabriel M.;
Wu, Joseph T.

Publication type:

Article